-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Karuna Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q4 2023.
- Karuna Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2023 was -$130M, a 52.4% decline year-over-year.
- Karuna Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2023 was -$495M, a 70.8% decline year-over-year.
- Karuna Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$495M, a 70.8% decline from 2022.
- Karuna Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$290M, a 101% decline from 2021.
- Karuna Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$144M, a 100% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)